Physicians in Germany intend to treat only 50% of individuals undergoing TNF-antagonists therapy, 40% of close contacts of patients with TB, 36% of individuals with HIV-infection and 25% of migrants with a positive result in the TST and/or IGRA. This evidence concerns the gene TNF and tuberculosis.